Increases the supply of oral contraceptives reimbursed by Social Security

-80 Per cent of women in fertile age today use some method of contraception in Spain

– However, only 16 per cent of fertile women use hormonal contraceptives after 33 years of access to the pill in our country

Madrid, July of 2011- there already is a new generation of contraceptives financed by Social Security. In this way response is given to one of the improvements included in the law on sexual and reproductive health and voluntary interruption of pregnancy 2, 2010 from March 3, 2010. From the Spanish Foundation of contraception, pursued its objectives closer to the population as much as possible different contraceptive methods its President Dr. Ezequiel Pérez Campos says that this has been a very important achievement: undoubtedly the considerable decrease in the price will help this approach, especially to disadvantaged sectors of the population. Public funding of contraception is one of the objectives of the Foundation ”

slight decline in the percentage of fertile women using the pill

El Dr. Iñaki Lethe, the Santiago Hospital in Vitoria-Gasteiz gynecologist confirms that according to the latest Daphne 2011 survey on contraceptive methods used by fertile women)(between 15 and 49 years) there has been a drop of two points from 18 per cent reflecting the European polls. This may be due to a hormonofobia that is common in the Mediterranean area and that is the product of the culture of these countries ”
by what this reluctance in our society, to the use of hormones? Dr. Jose Vicente Gonzalez of the Spanish Foundation of contraception stated that not only in contraception, also happens with treatments for menopause. And it has no basis, hormones are an essential part of our body, without them we could not live ”.

EFFIK launches Drosure ® / Drosurelle ®, it’s two OCs funded by the national health system which significantly reduced its final cost

Laboratories EFFIK, pharmaceutical company with more than 15 years of dedication to the health of women at the European level, announces that it has begun the commercialization of Drosure ® and Drosurelle ®, oral contraceptives of refund, no doubt a good news for women between 20 and 35 years old which are the main users of these contraceptive methods. As a result, its price is a very significant saving of current cost for the users. The composition of Drosure ® (0, 03 mg ethinyl estradiol and 3 mg drospirenone) and Drosurelle ® (0, 02 mg of ethinyl estradiol and 3 mg drospirenone) is exactly equal to contraceptives Yasmin and free price Yasminelle prescribed in our country.

Benefits of the drospirenone

Drospirenone, main ingredient of these new contraceptives, offers among its properties an antimineralcorticoide effect, giving it a biochemical and pharmacological profile very similar to natural progesterone.

Antimineralcorticoide activity prevents the sensation of fluid retention and weight gain ”, as said gynecologist Rafael Sánchez Borrego, President of the Association of studies of menopause who explains that there is a high drop-out among girls in the first three months of treatment with oral contraceptives, by which this effect of drospirenone avoid retention helps a lot to comply with ”. And as final Council places particular emphasis on the need that the professional explain clearly to women the process that is going to happen, informing her that in early may show some slight changes (retention of liquids..) but that they will not then present.

In addition, this active principle compensates for sodium retention caused by the estró¬genos, which gives rise to a very well tolerated and can have positive effects on symptoms in women before menstruation such as mammary tension headache, abdominal swelling, changes in mood, etc.

Two-thirds of women who demand the pill do to destine it to use solely contraceptive, being the remaining third representative of those who use it to reduce the premenstrual syndrome, control cycle or excessive bleeding, acne, or any type of demonstration androgen ” says Dr. Ezequiel Pérez Campos. The same expert confirmed that the drospirenone is used with very good results to decrease premenstrual syndrome disorders producing remarkable improvements.

About EFFIK, 15 years of experience in the care of women’s health

EFIIK Spain was born in 1996. Since then the company has experienced a gradual growth, and has now become a very consolidated pharmaceutical company in the field of gynaecology Spanish while maintaining a high degree of commitment with professionals and health institutions.

Effik mission is to meet the needs of public health, especially the health of women, offering innovative, safe and effective therapeutic solutions. Develops innovative solutions emerging from a close collaboration with the gynecologist, in response to their needs and the demands of his patients in order to contribute to achieving a proper state of health in the Spanish woman.

Effik has experience of 15 years in the service of the health of women offering safe, effective and innovative therapeutic solutions. We develop products to prevent, mitigate or cure diseases in the field of obstetrics, infectious diseases, contraception and fertility. Without a doubt – says Iñaki Carralero, Executive Vice President, EFFIK for Spain and Portugal – the launch of generic contraceptives, such as Drosure ® / Drosurelle ®, is a major step in women’s health, making them more accessible given its low cost, while maintaining the effectiveness and guarantees of free price contraceptives ”.